PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care
Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Meghalaya. According to a systematic review, the prevalence of pre-diabetes in Meghalaya is among the lowest in India at 2.4%. However, diabetes awareness in the state is also the lowest in the country, with only 14.4% of people aware of their condition. This indicates a critical gap in screening and early detection that leaves many patients undiagnosed and untreated.
The prevalence of hypertension is also notable. A 2025 study among young adults aged 18-25 years in urban Shillong found that 17.9% had elevated blood pressure. National data indicates that hypertension prevalence among youth in Meghalaya varies from 9.16% at the state level. The Lancet study found that 24.3% of people in Meghalaya suffer from hypertension.
The primary drivers include the traditional Meghalaya diet rich in high glycemic index foods like rice, high saturated fat from meat and fish preparations, and sugar-rich sweets combined with sedentary occupations, stressful urban living in cities like Shillong, declining physical activity, high tobacco consumption (52.5% currently), and alcohol use, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The state also has one of the highest cancer rates in India, with 176 cancer cases per one lakh population, further highlighting the burden of non-communicable diseases.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Meghalaya families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Meghalaya
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Meghalaya patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Meghalaya
Daksh works with hospitals, clinics, and pharmacies across Meghalaya to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community.
Popular Locations for PCD Pharma Franchise in Meghalaya
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Shillong | Cardiac diabetic PCD company in Shillong |
| PCD pharma franchise in Tura | Cardiac diabetic products in Tura |
| PCD pharma franchise in Jowai | Diabetic cardiac PCD franchise in Jowai |
| PCD pharma franchise in Nongstoin | Cardiac diabetic PCD company in Nongstoin |
| PCD pharma franchise in Baghmara | Cardiac diabetic products in Baghmara |
| PCD pharma franchise in Williamnagar | Diabetic cardiac PCD franchise in Williamnagar |
| PCD pharma franchise in Resubelpara | Cardiac diabetic PCD company in Resubelpara |
| PCD pharma franchise in Amlarem | Cardiac diabetic products in Amlarem |
| PCD pharma franchise in Mawkyrwat | Diabetic cardiac PCD franchise in Mawkyrwat |
| PCD pharma franchise in Mairang | Cardiac diabetic PCD company in Mairang |
Conclusion
The diabetes and heart disease burden in Meghalaya is not just a statistic it is a reality affecting thousands of families. With the state recording the lowest diabetes awareness in India at 14.4%, a hypertension prevalence of 24.3%, and high tobacco consumption (52.5%), the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |